Shawn Lin

Dr. Shawn Lin

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2026 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
STSimon Kang Seng Ting
Simon Kang Seng Ting
STSean Asahara Thio
Sean Asahara Thio
KCKe Cao
Ke Cao
SHShahul Hameed
Shahul Hameed
LWLi Weishan
Li Weishan
ANAdeline S. L. Ng
Adeline S. L. Ng


14 May 2024 in Clinical Case Reports
Verified
Journal Article
Open access
ZTZhibin Tan
Zhibin Tan
SLShawn Lin
Shawn Lin
YLYihan Li
Yihan Li
SKSi Wei Kheok
Si Wei Kheok
Key Clinical Message: In patients with lung adenocarcinoma, angiogenesis‐altering drugs can alter the appearance of leptomeningeal metastasis on magnetic resonance imaging (MRI) scans. In the ventral brainstem, this can manifest as a unique, linear, non‐enhancing T2‐hyperintense signal.

22 May 2024 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Closed access
PDF file
SLShawn Lin
Shawn Lin
MLMarco Lizwan
Marco Lizwan
SSSumit Kumar Sonu
Sumit Kumar Sonu

28 July 2026 in Neurology
Verified
Journal Article
Closed access
STSimon Kang Seng Ting
Simon Kang Seng Ting
Seyed Ehsan SaffariSeyed Ehsan Saffari
Seyed Ehsan Saffari
JZJinran Zhan
Jinran Zhan
TGTushar Divikar Gosavi
Tushar Divikar Gosavi
SHShahul Hameed
Shahul Hameed
ANAdeline S.L. Ng
Adeline S.L. Ng
Seizures are a recognized comorbidity in dementia, with varying prevalence across Alzheimer disease (AD) and dementia with Lewy bodies (DLBs). Although previous studies have demonstrated an increased seizure risk in AD, the neuropathologic substrates underlying seizure susceptibility-particularly across dementia subtypes-remain incompletely understood. We aimed to identify distinct clinicopathologic correlates of clinically active seizures in AD and DLB using a large autopsy-confirmed cohort. We conducted a retrospective cohort study using data from the National Alzheimer's Coordinating Center (2005-December 2022). Autopsy-confirmed AD and DLB cases were included. Individuals with a history of stroke or traumatic brain injury were excluded. The primary outcome was clinically active seizures, defined as seizures occurring within 3 years before or after the diagnosis of dementia. Neuropathologic exposures included Braak stage, cerebral amyloid angiopathy (CAA), frontotemporal lobar degeneration, and vascular pathologies. Multivariable logistic regression models were used to examine associations between pathologic features and seizure occurrence, adjusting for relevant demographic covariates. A total of 3,498 participants were included, comprising 3,040 with AD (mean age, 73.4 years; 48.5% female) and 458 with DLB (mean age, 75.1 years; 31.4% female). Active seizures were identified in 174 participants with AD (5.7%) and 13 with DLB (2.8%). In AD, Braak stage VI (vs V) was associated with higher odds of active seizures (adjusted odds ratio [OR], 1.81; 95% CI 1.20-2.82; p = 0.007), as was moderate to severe CAA (adjusted OR, 1.38; 95% CI 1.01-1.90; p = 0.045). In DLB, AD-related pathologic features were not associated with seizures. By contrast, vascular pathology was significantly associated with seizure occurrence, including microinfarcts (adjusted OR, 5.11; 95% CI 1.64-16.4; p = 0.005) and infarcts (adjusted OR, 4.11; 95% CI 1.27-12.9; p = 0.015). In this autopsy-confirmed cohort, seizure susceptibility was associated with advanced tau pathology and CAA in AD. In DLB, exploratory analyses suggested a possible association between vascular pathology and seizures; however, these findings should be interpreted cautiously. Overall, the results support potentially distinct pathologic contributions to seizure susceptibility across dementia subtypes. Limitations include the use of advanced-stage pathologic samples, which may limit generalizability to earlier disease stages.

30 June 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
WFWei Ting Foo
Wei Ting Foo
XHXiaoting Huang
Xiaoting Huang
SLShawn Lin
Shawn Lin
ACAnupama Roy Chowdhury
Anupama Roy Chowdhury
Background/Objectives: Mild cognitive impairment (MCI) is a clinically important state associated with an increased risk of future cognitive decline and dementia. Behaviour change interventions may support risk reduction and self-management in cognitively vulnerable adults. However, the extent to which the transtheoretical model (TTM) has been used in this population has not been clearly mapped. This scoping review examined TTM-based, TTM-informed, and TTM-congruent behaviour change interventions for adults with MCI, subjective cognitive concerns, or elevated dementia risk. Methods: This scoping review followed Joanna Briggs Institute guidance and was reported in accordance with PRISMA-ScR. The protocol was prospectively registered on the Open Science Framework. PubMed, PsycINFO, ScienceDirect, Scopus, Web of Science, CENTRAL, ProQuest Dissertations, and medRxiv were searched from inception to 30 September 2025. Eligible studies included randomised, nonrandomised, quasi-experimental, and qualitative designs. Data were charted using a piloted extraction form and were synthesised narratively. Results: Eight unique studies, represented across nine publications, were included. Only one trial explicitly operationalised the TTM in a clinically defined MCI cohort; most studies were more appropriately classified as TTM-informed or TTM-congruent. Recurrent intervention components included readiness alignment, goal setting, self-monitoring, personalised feedback, prompts and cues, problem solving, reinforcement, and relational support. Behavioural outcomes were more consistently favourable than cognitive outcomes, particularly for adherence, self-management, diet, and sustained physical activity engagement. Cognitive findings were heterogeneous: some smaller studies reported short-term improvements, whereas the largest rigorous trial found no significant cognitive benefit. Conclusions: Current evidence does not support strong claims regarding TTM-specific cognitive efficacy in MCI. Instead, it suggests that TTM-informed and TTM-congruent interventions may be useful for strengthening behavioural regulation, risk reduction, and maintenance of health-related routines in cognitively vulnerable adults. More rigorous studies are needed to test the TTM constructs prospectively and to determine whether proximal behavioural change translates into durable cognitive or functional benefit.